{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:21:17Z","timestamp":1782872477709,"version":"3.54.5"},"reference-count":141,"publisher":"National Institute for Health and Care Research","issue":"57","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["12\/167\/02"],"award-info":[{"award-number":["12\/167\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>Clinical trials show that antimicrobial-impregnated central venous catheters reduce catheter-related bloodstream infection in adults and children receiving intensive care, but there is insufficient evidence for use in newborn babies.<\/jats:p><\/jats:sec>Objectives<\/jats:title>The objectives were (1) to determine clinical effectiveness by conducting a randomised controlled trial comparing antimicrobial-impregnated peripherally inserted central venous catheters with standard peripherally inserted central venous catheters for reducing bloodstream or cerebrospinal fluid infections (referred to as bloodstream infections); (2) to conduct an economic evaluation of the costs, cost-effectiveness and value of conducting additional research; and (3) to conduct a generalisability analysis of trial findings to neonatal care in the NHS.<\/jats:p><\/jats:sec>Design<\/jats:title>Three separate studies were undertaken, each addressing one of the three objectives. (1) This was a multicentre, open-label, pragmatic randomised controlled trial; (2) an analysis was undertaken of hospital care costs, lifetime cost-effectiveness and value of information from an NHS perspective; and (3) this was a retrospective cohort study of bloodstream infection rates in neonatal units in England.<\/jats:p><\/jats:sec>Setting<\/jats:title>The randomised controlled trial was conducted in 18 neonatal intensive care units in England.<\/jats:p><\/jats:sec>Participants<\/jats:title>Participants were babies who required a peripherally inserted central venous catheter (of 1 French gauge in size).<\/jats:p><\/jats:sec>Interventions<\/jats:title>The interventions were an antimicrobial-impregnated peripherally inserted central venous catheter (coated with rifampicin\u2013miconazole) or a standard peripherally inserted central venous catheter, allocated randomly (1\u2009:\u20091) using web randomisation.<\/jats:p><\/jats:sec>Main outcome measure<\/jats:title>Study 1 \u2013 time to first bloodstream infection, sampled between 24 hours after randomisation and 48 hours after peripherally inserted central venous catheter removal. Study 2 \u2013 cost-effectiveness of the antimicrobial-impregnated peripherally inserted central venous catheter compared with the standard peripherally inserted central venous catheters. Study 3 \u2013 risk-adjusted bloodstream rates in the trial compared with those in neonatal units in England. For study 3, the data used were as follows: (1) case report forms and linked death registrations; (2) case report forms and linked death registrations linked to administrative health records with 6-month follow-up; and (3) neonatal health records linked to infection surveillance data.<\/jats:p><\/jats:sec>Results<\/jats:title>Study 1, clinical effectiveness \u2013 861 babies were randomised (antimicrobial-impregnated peripherally inserted central venous catheter,n<\/jats:italic>\u2009=\u2009430; standard peripherally inserted central venous catheter,n<\/jats:italic>\u2009=\u2009431). Bloodstream infections occurred in 46 babies (10.7%) randomised to antimicrobial-impregnated peripherally inserted central venous catheters and in 44 (10.2%) babies randomised to standard peripherally inserted central venous catheters. No difference in time to bloodstream infection was detected (hazard ratio 1.11, 95% confidence interval 0.73 to 1.67;p<\/jats:italic>\u2009=\u20090.63). Secondary outcomes of rifampicin resistance in positive blood\/cerebrospinal fluid cultures, mortality, clinical outcomes at neonatal unit discharge and time to peripherally inserted central venous catheter removal were similar in both groups. Rifampicin resistance in positive peripherally inserted central venous catheter tip cultures was higher in the antimicrobial-impregnated peripherally inserted central venous catheter group (relative risk 3.51, 95% confidence interval 1.16 to 10.57;p<\/jats:italic>\u2009=\u20090.02) than in the standard peripherally inserted central venous catheter group. Adverse events were similar in both groups. Study 2, economic evaluation \u2013 the mean cost of babies\u2019 hospital care was \u00a383,473. Antimicrobial-impregnated peripherally inserted central venous catheters were not cost-effective. Given the increased price, compared with standard peripherally inserted central venous catheters, the minimum reduction in risk of bloodstream infection for antimicrobial-impregnated peripherally inserted central venous catheters to be cost-effective was 3% and 15% for babies born at 23\u201327 and 28\u201332 weeks\u2019 gestation, respectively. Study 3, generalisability analysis \u2013 risk-adjusted bloodstream infection rates per 1000 peripherally inserted central venous catheter days were similar among babies in the trial and in all neonatal units. Of all bloodstream infections in babies receiving intensive or high-dependency care in neonatal units, 46% occurred during peripherally inserted central venous catheter days.<\/jats:p><\/jats:sec>Limitations<\/jats:title>The trial was open label as antimicrobial-impregnated and standard peripherally inserted central venous catheters are different colours. There was insufficient power to determine differences in rifampicin resistance.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>No evidence of benefit or harm was found of peripherally inserted central venous catheters impregnated with rifampicin\u2013miconazole during neonatal care. Interventions with small effects on bloodstream infections could be cost-effective over a child\u2019s life course. Findings were generalisable to neonatal units in England. Future research should focus on other types of antimicrobial impregnation of peripherally inserted central venous catheters and alternative approaches for preventing bloodstream infections in neonatal care.<\/jats:p><\/jats:sec>Trial registration<\/jats:title>Current Controlled Trials ISRCTN81931394.<\/jats:p><\/jats:sec>Funding<\/jats:title>This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full inHealth Technology Assessment<\/jats:italic>; Vol. 24, No. 57. See the NIHR Journals Library website for further project information.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta24570","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T12:49:08Z","timestamp":1605098948000},"page":"1-190","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT"],"prefix":"10.3310","volume":"24","clinical-trial-number":[{"clinical-trial-number":"isrctn81931394","registry":"10.18810\/isrctn","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9347-2709","authenticated-orcid":true,"given":"Ruth","family":"Gilbert","sequence":"first","affiliation":[{"name":"UCL Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London, London, UK"},{"name":"Health Data Research UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-271X","authenticated-orcid":true,"given":"Michaela","family":"Brown","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-1435","authenticated-orcid":true,"given":"Rita","family":"Faria","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7260-7053","authenticated-orcid":true,"given":"Caroline","family":"Fraser","sequence":"additional","affiliation":[{"name":"UCL Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6379-8214","authenticated-orcid":true,"given":"Chloe","family":"Donohue","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-3946","authenticated-orcid":true,"given":"Naomi","family":"Rainford","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-438X","authenticated-orcid":true,"given":"Alessandro","family":"Grosso","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5201-7718","authenticated-orcid":true,"given":"Ajay K","family":"Sinha","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-3221","authenticated-orcid":true,"given":"Jon","family":"Dorling","sequence":"additional","affiliation":[{"name":"Division of Neonatal\u2013Perinatal Medicine, Dalhousie University IWK Health Centre, Halifax, NS, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-3141","authenticated-orcid":true,"given":"Jim","family":"Gray","sequence":"additional","affiliation":[{"name":"Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-480X","authenticated-orcid":true,"given":"Berit","family":"Muller-Pebody","sequence":"additional","affiliation":[{"name":"National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-2856","authenticated-orcid":true,"given":"Katie","family":"Harron","sequence":"additional","affiliation":[{"name":"UCL Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-996X","authenticated-orcid":true,"given":"Tracy","family":"Moitt","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-514X","authenticated-orcid":true,"given":"William","family":"McGuire","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-9109","authenticated-orcid":true,"given":"Laura","family":"Bojke","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-1955","authenticated-orcid":true,"given":"Carrol","family":"Gamble","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-4912","authenticated-orcid":true,"given":"Sam J","family":"Oddie","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination, University of York, York, UK"},{"name":"Bradford Neonatology, Bradford Royal Infirmary, Bradford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2020,11]]},"reference":[{"key":"key20201109183027267_ref1-bib1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S2352-4642(19)30114-2","article-title":"Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial","volume":"3","author":"Gilbert","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"key20201109183027267_ref1-bib2","unstructured":"Office for National Statistics. Birth Characteristics in England and Wales: 2017. Newport: Office for National Statistics; 2019."},{"key":"key20201109183027267_ref1-bib3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/pr.2013.204","article-title":"Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"key20201109183027267_ref1-bib4","doi-asserted-by":"publisher","first-page":"e7976","DOI":"10.1136\/bmj.e7976","article-title":"Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies)","volume":"345","author":"Costeloe","year":"2012","journal-title":"BMJ"},{"key":"key20201109183027267_ref1-bib5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.puhe.2014.03.010","article-title":"Outcomes in preterm infants","volume":"128","author":"Platt","year":"2014","journal-title":"Public Health"},{"key":"key20201109183027267_ref1-bib6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet"},{"key":"key20201109183027267_ref1-bib7","doi-asserted-by":"publisher","first-page":"e0180134","DOI":"10.1371\/journal.pone.0180134","article-title":"Pathogen-specific mortality in very low birth weight infants with primary bloodstream infection","volume":"12","author":"Piening","year":"2017","journal-title":"PLOS ONE"},{"key":"key20201109183027267_ref1-bib8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3476(96)70191-9","article-title":"Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network","volume":"129","author":"Stoll","year":"1996","journal-title":"J Pediatr"},{"key":"key20201109183027267_ref1-bib9","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1542\/peds.2012-3979","article-title":"Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants","volume":"132","author":"Mitha","year":"2013","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib10","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.292.19.2357","article-title":"Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection","volume":"292","author":"Stoll","year":"2004","journal-title":"JAMA"},{"key":"key20201109183027267_ref1-bib11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-3782(12)70019-1","article-title":"Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units","volume":"88","author":"Hornik","year":"2012","journal-title":"Early Hum Dev"},{"key":"key20201109183027267_ref1-bib12","doi-asserted-by":"publisher","first-page":"F547","DOI":"10.1136\/archdischild-2017-313203","article-title":"Epidemiology of UK neonatal infections: the neonIN infection surveillance network","volume":"103","author":"Cailes","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key20201109183027267_ref1-bib13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/apa.12779","article-title":"Skin colonisation at the catheter exit site is strongly associated with catheter colonisation and catheter-related sepsis","volume":"103","author":"Ponnusamy","year":"2014","journal-title":"Acta Paediatr"},{"key":"key20201109183027267_ref1-bib14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/clinids\/12.supplement_4.s410","article-title":"Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection","volume":"12","author":"Wilson","year":"1990","journal-title":"Rev Infect Dis"},{"key":"key20201109183027267_ref1-bib15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1523-1747.1998.00289.x","article-title":"Development of skin barrier function in premature infants","volume":"111","author":"Kalia","year":"1998","journal-title":"J Invest Dermatol"},{"key":"key20201109183027267_ref1-bib16","unstructured":"National Neonatal Audit Programme. National Neonatal Audit Programme 2018 Report on 2017 Data. London: Royal College of Paediatrics and Child Health; 2018."},{"key":"key20201109183027267_ref1-bib17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1542\/peds.2009-2959","article-title":"Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network","volume":"126","author":"Stoll","year":"2010","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2047-2994-2-11","article-title":"The impact of staffing on central venous catheter-associated bloodstream infections in preterm neonates \u2013 results of nation-wide cohort study in Germany","volume":"2","author":"Leistner","year":"2013","journal-title":"Antimicrob Resist Infect Control"},{"key":"key20201109183027267_ref1-bib20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/j.1651-2227.2009.01322.x","article-title":"Nosocomial infection in a Danish neonatal intensive care unit: a prospective study","volume":"98","author":"Olsen","year":"2009","journal-title":"Acta Paediatr"},{"key":"key20201109183027267_ref1-bib21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fped.2017.00142","article-title":"Bloodstream infection incidence of different central venous catheters in neonates: a descriptive cohort study","volume":"5","author":"Dubbink-Verheij","year":"2017","journal-title":"Front Pediatr"},{"key":"key20201109183027267_ref1-bib22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0148607108327526","article-title":"Biofilms, infection, and parenteral nutrition therapy","volume":"33","author":"Machado","year":"2009","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"key20201109183027267_ref1-bib23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"key20201109183027267_ref1-bib24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008436.pub3","article-title":"Early removal versus expectant management of central venous catheters in neonates with bloodstream infection","volume":"4","author":"Vasudevan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key20201109183027267_ref1-bib25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jpeds.2011.02.035","article-title":"Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis","volume":"159","author":"Alexander","year":"2011","journal-title":"J Pediatr"},{"key":"key20201109183027267_ref1-bib26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jpeds.2011.05.033","article-title":"Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants","volume":"159","author":"Kuppala","year":"2011","journal-title":"J Pediatr"},{"key":"key20201109183027267_ref1-bib27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0195-6701(13)60012-2","article-title":"Epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England","volume":"86","author":"Loveday","year":"2014","journal-title":"J Hosp Infect"},{"key":"key20201109183027267_ref1-bib28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajic.2011.01.003","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"39","author":"O\u2019Grady","year":"2011","journal-title":"Am J Infect Control"},{"key":"key20201109183027267_ref1-bib29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011078.pub2","article-title":"Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants","volume":"9","author":"Balain","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key20201109183027267_ref1-bib30","first-page":"1477","article-title":"A randomized controlled trial to evaluate antibiotic impregnated percutaneously introduced central (PIC-) lines in preterm infants","volume":"175","author":"Flemmer","year":"2016","journal-title":"Eur J Pediatr"},{"key":"key20201109183027267_ref1-bib31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2010.04.025","article-title":"Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis","volume":"76","author":"Wang","year":"2010","journal-title":"J Hosp Infect"},{"key":"key20201109183027267_ref1-bib32","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1093\/cid\/cix019","article-title":"Comparative efficacy of antimicrobial central venous catheters in reducing catheter-related bloodstream infections in adults: abridged cochrane systematic review and network meta-analysis","volume":"64","author":"Chong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key20201109183027267_ref1-bib33","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00134-017-4777-1","article-title":"Impregnated central venous catheters in children: a systematic review of randomized controlled trials","volume":"43","author":"Wu","year":"2017","journal-title":"Intensive Care Med"},{"key":"key20201109183027267_ref1-bib34","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/S0140-6736(16)00340-8","article-title":"Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial","volume":"387","author":"Gilbert","year":"2016","journal-title":"Lancet"},{"key":"key20201109183027267_ref1-bib35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007878.pub3","article-title":"Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults","volume":"3","author":"Lai","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key20201109183027267_ref1-bib36","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/jac\/dkh483","article-title":"Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial","volume":"54","author":"Y\u00fccel","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key20201109183027267_ref1-bib37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/01.CCM.0000201404.05523.34","article-title":"A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters","volume":"34","author":"Fraenkel","year":"2006","journal-title":"Crit Care Med"},{"key":"key20201109183027267_ref1-bib38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/jpids\/pis066","article-title":"A randomized, controlled trial of catheter-related infectious event rates using antibiotic-impregnated catheters versus conventional catheters in pediatric cardiovascular surgery patients","volume":"2","author":"Cox","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key20201109183027267_ref1-bib39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.sla.0000171874.29934.61","article-title":"Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial","volume":"242","author":"Darouiche","year":"2005","journal-title":"Ann Surg"},{"key":"key20201109183027267_ref1-bib40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199901073400101","article-title":"A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group","volume":"340","author":"Darouiche","year":"1999","journal-title":"N Engl J Med"},{"key":"key20201109183027267_ref1-bib41","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2004.04.124","article-title":"Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20201109183027267_ref1-bib42","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00134-004-2378-2","article-title":"Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial","volume":"30","author":"Le\u00f3n","year":"2004","journal-title":"Intensive Care Med"},{"key":"key20201109183027267_ref1-bib43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/00003246-199906000-00034","article-title":"The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters","volume":"27","author":"Marik","year":"1999","journal-title":"Critical Care Med"},{"key":"key20201109183027267_ref1-bib44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7326\/0003-4819-127-4-199708150-00002","article-title":"Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group","volume":"127","author":"Raad","year":"1997","journal-title":"Ann Intern Med"},{"key":"key20201109183027267_ref1-bib45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jac\/46.1.45","article-title":"The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity","volume":"46","author":"Schierholz","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key20201109183027267_ref1-bib46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/QCO.0b013e3283297b68","article-title":"Using care bundles to prevent infection in neonatal and paediatric ICUs","volume":"22","author":"Lachman","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"key20201109183027267_ref1-bib47","doi-asserted-by":"publisher","first-page":"F422","DOI":"10.1136\/archdischild-2017-313362","article-title":"Care bundles to reduce central line-associated bloodstream infections in the neonatal unit: a systematic review and meta-analysis","volume":"103","author":"Payne","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key20201109183027267_ref1-bib48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/INF.0000000000001019","article-title":"Prevention of late onset sepsis and central-line associated blood stream infection in preterm infants","volume":"35","author":"Sinha","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"key20201109183027267_ref1-bib49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"Peto","year":"1976","journal-title":"Br J Cancer"},{"key":"key20201109183027267_ref1-bib50","volume-title":"Births in England and Wales: Summary Tables","author":"Office for National Statistics","year":"2019"},{"key":"key20201109183027267_ref1-bib51","volume-title":"Neonatal Critical Care","author":"NHS England","year":"2013"},{"key":"key20201109183027267_ref1-bib52","volume-title":"Parent Information Sheet and Consent Form Version 6.0: 12\/10\/2015","author":"The PREVAIL Trial","year":"2015"},{"key":"key20201109183027267_ref1-bib53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/jhin.2002.1358","article-title":"Pharmacokinetics of the antimicrobial agents rifampicin and miconazole released from a loaded central venous catheter","volume":"53","author":"Rump","year":"2003","journal-title":"J Hosp Infect"},{"key":"key20201109183027267_ref1-bib54","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key20201109183027267_ref1-bib55","doi-asserted-by":"publisher","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLOS Med"},{"key":"key20201109183027267_ref1-bib56","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1741-7015-11-80","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"11","author":"Husereau","year":"2013","journal-title":"BMC Med"},{"key":"key20201109183027267_ref1-bib57","volume-title":"ICH E9 Statistical Principles for Clinical Trials","author":"European Medicines Agency","year":"1998"},{"key":"key20201109183027267_ref1-bib58","volume-title":"PREVAIL Statistical Analysis Plan for Final Analysis Version 3.0 28\/03\/2018","author":"Bacon","year":"2018"},{"key":"key20201109183027267_ref1-bib59","volume-title":"PREVenting infection using Antimicrobial Impregnated Long lines (PREVAIL) Protocol v5.0","author":"Gilbert","year":"2017"},{"key":"key20201109183027267_ref1-bib60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(SICI)1099-1050(199905)8:3<269::AID-HEC425>3.0.CO;2-D","article-title":"Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals","volume":"8","author":"Claxton","year":"1999","journal-title":"Health Econ"},{"key":"key20201109183027267_ref1-bib61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0272989X16645577","article-title":"How to invest in getting cost-effective technologies into practice? A framework for value of implementation analysis applied to novel oral anticoagulants","volume":"37","author":"Faria","year":"2017","journal-title":"Med Decis Making"},{"key":"key20201109183027267_ref1-bib62","volume-title":"NHS Reference Costs 2015 to 2016","author":"Department of Health and Social Care"},{"key":"key20201109183027267_ref1-bib63","volume-title":"Case Report Form Completion Booklet","author":"The PREVAIL trial"},{"key":"key20201109183027267_ref1-bib64","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/archdischild-2015-309928","article-title":"The UK National Neonatal Research Database: using neonatal data for research, quality improvement and more","volume":"101","author":"Gale","year":"2016","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"key20201109183027267_ref1-bib65","volume-title":"National Neonatal Data Set Overview","author":"NHS"},{"key":"key20201109183027267_ref1-bib66","unstructured":"Paediatric Intensive Care Audit Network (PICANet). Paediatric Intensive Care Audit Network: Annual Report 2018. Leeds and Leicester: University of Leeds and University of Leicester; 2018."},{"key":"key20201109183027267_ref1-bib67","volume-title":"Hospital Episode Statistics (HES)","author":"NHS Digital"},{"key":"key20201109183027267_ref1-bib68","volume-title":"Casemix Companion \u2013 HRG4+ 2016\/2017 Reference Costs Grouper","author":"National Casemix Office, NHS Digital","year":"2017"},{"key":"key20201109183027267_ref1-bib69","unstructured":"Department of Health and Social Care. Reference Costs Guidance 2015 to 2016. London: Department of Health and Social Care; 2016."},{"key":"key20201109183027267_ref1-bib70","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"PharmacoEconomics"},{"key":"key20201109183027267_ref1-bib71","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1542\/peds.2008-1827","article-title":"The cost of preterm birth throughout childhood in England and Wales","volume":"123","author":"Mangham","year":"2009","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib72","unstructured":"National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013."},{"issue":"18","key":"key20201109183027267_ref1-bib73","doi-asserted-by":"publisher","DOI":"10.3310\/hta20180","article-title":"CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children","volume":"20","author":"Harron","year":"2016","journal-title":"Health Technol Assess"},{"key":"key20201109183027267_ref1-bib74","doi-asserted-by":"publisher","first-page":"e34857","DOI":"10.1542\/peds.2010-3338","article-title":"Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants","volume":"128","author":"Schlapbach","year":"2011","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib75","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/archpedi.154.7.725","article-title":"Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000\u2009g: 1992\u20131995","volume":"154","author":"Hack","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key20201109183027267_ref1-bib76","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1542\/peds.2008-0377","article-title":"Trial of Indomethacin Prophylaxis in Preterms Investigators. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection","volume":"123","author":"Bassler","year":"2009","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib77","doi-asserted-by":"publisher","first-page":"170175.e1","DOI":"10.1016\/j.jpeds.2008.02.033","article-title":"Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term","volume":"153","author":"Shah","year":"2008","journal-title":"J Pediatr"},{"key":"key20201109183027267_ref1-bib78","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jamapediatrics.2013.1199","article-title":"Perinatal infections and neurodevelopmental outcome in very preterm and very low-birth-weight infants: a meta-analysis","volume":"167","author":"van Vliet","year":"2013","journal-title":"JAMA Pediatr"},{"key":"key20201109183027267_ref1-bib79","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/jp.2012.167","article-title":"Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis","volume":"33","author":"Alshaikh","year":"2013","journal-title":"J Perinatol"},{"key":"key20201109183027267_ref1-bib80","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/apa.12764","article-title":"Meta-analysis shows that infants who have suffered neonatal sepsis face an increased risk of mortality and severe complications","volume":"103","author":"Bakhuizen","year":"2014","journal-title":"Acta Paediatr"},{"key":"key20201109183027267_ref1-bib81","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1542\/peds.2004-0569","article-title":"Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis","volume":"115","author":"Hintz","year":"2005","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib82","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jpeds.2010.05.042","article-title":"Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia","volume":"157","author":"Martin","year":"2010","journal-title":"J Pediatr"},{"key":"key20201109183027267_ref1-bib83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.earlhumdev.2004.05.009","article-title":"Neonatal intensive care at borderline viability \u2013 is it worth it?","volume":"80","author":"Doyle","year":"2004","journal-title":"Early Hum Dev"},{"key":"key20201109183027267_ref1-bib84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1440-1754.1997.tb01021.x","article-title":"Outcome at 2 years of children 23\u201327 weeks\u2019 gestation born in Victoria in 1991\u201392","volume":"33","author":"Doyle","year":"1997","journal-title":"J Paediatr Child Health"},{"key":"key20201109183027267_ref1-bib85","doi-asserted-by":"publisher","first-page":"F484","DOI":"10.1136\/adc.2004.063362","article-title":"Improved neurosensory outcome at 8 years of age of extremely low birthweight children born in Victoria over three distinct eras","volume":"90","author":"Doyle","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key20201109183027267_ref1-bib86","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"key20201109183027267_ref1-bib87","doi-asserted-by":"publisher","first-page":"F208","DOI":"10.1136\/archdischild-2017-312748","article-title":"Survival of very preterm infants admitted to neonatal care in England 2008\u20132014: time trends and regional variation","volume":"103","author":"Santhakumaran","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key20201109183027267_ref1-bib88","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/NEJM200106283442602","article-title":"Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants","volume":"344","author":"Schmidt","year":"2001","journal-title":"N Engl J Med"},{"key":"key20201109183027267_ref1-bib89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa041367","article-title":"Neurologic and developmental disability at six years of age after extremely preterm birth","volume":"352","author":"Marlow","year":"2005","journal-title":"N Engl J Med"},{"key":"key20201109183027267_ref1-bib90","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJM200008103430601","article-title":"Neurologic and developmental disability after extremely preterm birth. EPICure Study Group","volume":"343","author":"Wood","year":"2000","journal-title":"N Engl J Med"},{"key":"key20201109183027267_ref1-bib91","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1542\/peds.112.6.1290","article-title":"The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life","volume":"112","author":"Petrou","year":"2003","journal-title":"Pediatrics"},{"key":"key20201109183027267_ref1-bib92","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/bmj.296.6621.583","article-title":"Trends in episode based and person based rates of admission to hospital in the Oxford record linkage study area","volume":"296","author":"Goldacre","year":"1988","journal-title":"Br Med J"},{"key":"key20201109183027267_ref1-bib93","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/jech.47.4.316","article-title":"Computerised linking of medical records: methodological guidelines","volume":"47","author":"Gill","year":"1993","journal-title":"J Epidemiol Community Health"},{"key":"key20201109183027267_ref1-bib94","first-page":"1353","article-title":"Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter","volume":"30","author":"Schierholz","year":"2010","journal-title":"Anticancer Res"},{"key":"key20201109183027267_ref1-bib95","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0022-3476(05)82215-2","article-title":"Changing two-year outcome of infants weighing 500 to 999 grams at birth: a hospital study","volume":"118","author":"Kitchen","year":"1991","journal-title":"J Pediatr"},{"key":"key20201109183027267_ref1-bib96","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2214.2012.01368.x","article-title":"The association between neurodevelopmental disability and economic outcomes during mid-childhood","volume":"39","author":"Petrou","year":"2013","journal-title":"Child Care Health Dev"},{"key":"key20201109183027267_ref1-bib97","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1524-4733.2009.00580.x","article-title":"Costs and health utilities associated with extremely preterm birth: evidence from the EPICure study","volume":"12","author":"Petrou","year":"2009","journal-title":"Value Health"},{"key":"key20201109183027267_ref1-bib98","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1469-8749.2012.04218.x","article-title":"Survival of individuals with cerebral palsy born in Victoria, Australia, between 1970 and 2004","volume":"54","author":"Reid","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"key20201109183027267_ref1-bib99","unstructured":"Office for National Statistics. National Life Tables, UK: 2013\u20132015. Newport: Office for National Statistics; 2016."},{"key":"key20201109183027267_ref1-bib100","volume-title":"Modelling the Long-term Costs of Preterm Birth","author":"Mangham","year":"2008"},{"key":"key20201109183027267_ref1-bib101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2006.01.002","article-title":"Pushing the boundaries of viability: the economic impact of extreme preterm birth","volume":"82","author":"Petrou","year":"2006","journal-title":"Early Hum Dev"},{"issue":"14","key":"key20201109183027267_ref1-bib102","doi-asserted-by":"publisher","DOI":"10.3310\/hta19140","article-title":"Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold","volume":"19","author":"Claxton","year":"2015","journal-title":"Health Technol Assess"},{"key":"key20201109183027267_ref1-bib103","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"key":"key20201109183027267_ref1-bib104","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"Ara","year":"2010","journal-title":"Value Health"},{"key":"key20201109183027267_ref1-bib105","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40273-015-0327-2","article-title":"AdViSHE: A validation-assessment tool of health-economic models for decision makers and model users","volume":"34","author":"Vemer","year":"2016","journal-title":"PharmacoEconomics"},{"key":"key20201109183027267_ref1-bib106","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/archdischild-2019-317640","article-title":"The cost-effectiveness of strategies preventing late-onset infection in preterm infants","volume":"105","author":"Grosso","year":"2020","journal-title":"Arch Dis Child"},{"key":"key20201109183027267_ref1-bib107","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0167-6296(98)00039-3","article-title":"The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies","volume":"18","author":"Claxton","year":"1999","journal-title":"J Health Econ"},{"key":"key20201109183027267_ref1-bib108","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0272989X15575286","article-title":"Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast, nonparametric regression-based method","volume":"35","author":"Strong","year":"2015","journal-title":"Med Decis Making"},{"key":"key20201109183027267_ref1-bib109","doi-asserted-by":"publisher","first-page":"F466","DOI":"10.1136\/archdischild-2017-313291","article-title":"Assessing the accuracy of the National Neonatal Audit Programme calculated central line-associated bloodstream infection rate from local data","volume":"102","author":"Ismail","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key20201109183027267_ref1-bib110","unstructured":"National Neonatal Audit Programme. National Neonatal Audit Programme 2017 Report on 2016 Data. London: Royal College of Paediatrics and Child Health; 2017."},{"key":"key20201109183027267_ref1-bib111","doi-asserted-by":"publisher","first-page":"e0226040","DOI":"10.1371\/journal.pone.0226040","article-title":"Linking surveillance and clinical data for evaluating trends in bloodstream infection rates in neonatal units in England","volume":"14","author":"Fraser","year":"2019","journal-title":"PLOS ONE"},{"key":"key20201109183027267_ref1-bib112","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/01621459.1969.10501049","article-title":"A theory for record linkage","volume":"64","author":"Fellegi","year":"1969","journal-title":"J Am Stat Assoc"},{"key":"key20201109183027267_ref1-bib113","doi-asserted-by":"publisher","first-page":"a027011","DOI":"10.1101\/cshperspect.a027011","article-title":"Rifamycins, alone and in combination","volume":"6","author":"Rothstein","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20201109183027267_ref1-bib114","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ajic.2016.07.021","article-title":"Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis","volume":"45","author":"Kramer","year":"2017","journal-title":"Am J Infect Control"},{"key":"key20201109183027267_ref1-bib115","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0732-8893(89)90022-9","article-title":"In vitro activity of minocycline and rifampin against staphylococci","volume":"12","author":"Segreti","year":"1989","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20201109183027267_ref1-bib116","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/s00134-007-0897-3","article-title":"Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials","volume":"33","author":"Ni\u00ebl-Weise","year":"2007","journal-title":"Intensive Care Med"},{"key":"key20201109183027267_ref1-bib117","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.clp.2010.04.001","article-title":"Role of innate host defenses in susceptibility to early-onset neonatal sepsis","volume":"37","author":"Wynn","year":"2010","journal-title":"Clin Perinatol"},{"key":"key20201109183027267_ref1-bib118","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hec.1093","article-title":"Whither trial-based economic evaluation for health care decision making?","volume":"15","author":"Sculpher","year":"2006","journal-title":"Health Econ"},{"key":"key20201109183027267_ref1-bib119","doi-asserted-by":"publisher","first-page":"30143","DOI":"10.2807\/1560-7917.ES.2016.21.8.30143","article-title":"Neurological sequelae of healthcare-associated sepsis in very-low-birthweight infants: umbrella review and evidence-based outcome tree","volume":"21","author":"Haller","year":"2016","journal-title":"Euro Surveill"},{"key":"key20201109183027267_ref1-bib120","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/QCO.0000000000000061","article-title":"The neonatal bowel microbiome in health and infection","volume":"27","author":"Berrington","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key20201109183027267_ref1-bib121","volume-title":"Appropriate Perspectives for Health Care Decisions","author":"Claxton","year":"2010"},{"key":"key20201109183027267_ref1-bib122","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40273-018-0722-6","article-title":"Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England","volume":"37","author":"Tubeuf","year":"2019","journal-title":"PharmacoEconomics"},{"key":"key20201109183027267_ref1-bib123","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/0272989X14541328","article-title":"Measuring family HRQoL spillover effects using direct health utility assessment","volume":"35","author":"Prosser","year":"2015","journal-title":"Med Decis Making"},{"key":"key20201109183027267_ref1-bib124","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/CCM.0b013e3181958915","article-title":"The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review","volume":"37","author":"Hockenhull","year":"2009","journal-title":"Crit Care Med"},{"key":"key20201109183027267_ref1-bib125","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1097\/00003246-200009000-00035","article-title":"Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters","volume":"28","author":"Marin","year":"2000","journal-title":"Crit Care Med"},{"key":"key20201109183027267_ref1-bib126","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.282.6.554","article-title":"Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection","volume":"282","author":"Veenstra","year":"1999","journal-title":"JAMA"},{"key":"key20201109183027267_ref1-bib127","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/cc7744","article-title":"Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision","volume":"13","author":"Halton","year":"2009","journal-title":"Crit Care"},{"key":"key20201109183027267_ref1-bib128","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/0272989X11406986","article-title":"A framework for addressing structural uncertainty in decision models","volume":"31","author":"Jackson","year":"2011","journal-title":"Med Decis Making"},{"key":"key20201109183027267_ref1-bib129","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(18)32221-9","article-title":"Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial","volume":"393","author":"The ELFIN trial investigators group","year":"2019","journal-title":"Lancet"},{"key":"key20201109183027267_ref1-bib130","volume-title":"Outcome After Selective Early Closure of Ductus Arteriosus in Extremely Preterm Babies (Baby-OSCAR Trial)","author":"National Institute for Health Research"},{"key":"key20201109183027267_ref1-bib131","volume-title":"Neonatal and Paediatric Pharmacokinetics of Antimicrobials Study (NAPPA)","author":"ClinicalTrials.gov"},{"key":"key20201109183027267_ref1-bib132","unstructured":"Great Britain. Data Protection Act 2018. London: The Stationery Office; 2018."},{"key":"key20201109183027267_ref1-bib133","volume-title":"NHS Reference Costs 2014 to 2015","author":"Department of Health and Social Care"},{"key":"key20201109183027267_ref1-bib134","volume-title":"NHS Reference Costs 2016\/17","author":"NHS Improvement"},{"key":"key20201109183027267_ref1-bib135","volume-title":"Unit Costs of Health and Social Care 2017","author":"Curtis","year":"2017"},{"key":"key20201109183027267_ref1-bib136","volume-title":"Users, Uses and Access to Hospital Episode Statistics","author":"NHS Digital"},{"key":"key20201109183027267_ref1-bib137","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40273-014-0205-3","article-title":"Bidirectional citation searching to completion: an exploration of literature searching methods","volume":"33","author":"Hinde","year":"2015","journal-title":"PharmacoEconomics"},{"key":"key20201109183027267_ref1-bib138","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ije\/dyv322","article-title":"Probabilistic record linkage","volume":"45","author":"Sayers","year":"2016","journal-title":"Int J Epidemiol"},{"key":"key20201109183027267_ref1-bib139","doi-asserted-by":"publisher","DOI":"10.1177\/2053951717745678","article-title":"Challenges in administrative data linkage for research","volume":"4","author":"Harron","year":"2017","journal-title":"Big Data Soc"},{"key":"key20201109183027267_ref1-bib140","unstructured":"Public Health England. Laboratory Reporting to Public Health England: A Guide for Diagnostic Laboratories. London: Public Health England; 2016."},{"key":"key20201109183027267_ref1-bib141","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Lopez Bernal","year":"2016","journal-title":"Int J Epidemiol"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2034745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta24570\/hta24570.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2034745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T07:29:55Z","timestamp":1723879795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta24570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":141,"journal-issue":{"issue":"57","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["10.3310\/hta24570"],"URL":"https:\/\/doi.org\/10.3310\/hta24570","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"12-2014","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"9-2019","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"5-2020","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}